you answered your own question. The business has stabilised and we will now see growth on the top and bottom line. The shorts have nothing to hang their hats on.
seasonal slowdown in their 1st Q because of summer holidays. Compare the same Q last year where they had $168M in revenue and you will see they are projecting a min of 5% sales growth for the Q. Now then who's hysterical
Also if you do a search on YouTube for Trinity Biotech you will find a couple of videos put out by the company.
The Meritas video is quite good
This video is on YouTube. The potential is very good and the video backs up what management has been saying. https://www.youtube.com/watch?v=B0hCcgzxdsc
i bet they announce that they have bought some stock back and that they are looking at a couple of potential purchases. Good Dry eye, Syphilas and Troponin updates are more important.